[Value of CEA determination in follow-up of patients with liver metastasis of colorectal cancers with loco-regional chemotherapy].
The importance of carcinoembryonic antigen as a tumor marker to the follow-up of patients with liver metastases from colorectal cancer was investigated. It was reported about 29 patients receiving chemotherapy. We estimated the effect of therapy according to sonographic and computer tomographic criteria and related to the CEA-level. The correlation of the growth of cancer and the level of the CEA was positive in 81% of the patients. We do not consider as sufficient the measurement of CEA as an exclusive method for the follow-up of colorectal cancer and recommend the monthly measurement of CEA in connection with radiological examinations in the period of 3-4 month.
Schimpfle
B
B
Klinik für Chirurgie, Medizinischen Fakultät (Charité) Humboldt-Universität zu Berlin.
Matthias
M
M
Wolff
H
H
Mai
C
C
Lüning
M
M
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D015996:Survival Rate
D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D005472:Fluorouracil
Der Stellenwert der CEA-Bestimmung in der Verlaufskontrolle von Patienten mit Lebermetastasen kolorektaler Karzinome unter lokoregionaler Chemotherapie.